Looking for a new product

empty shelves
The manufacturer of testosterone replacement therapy Testogel says it will work with health professionals to fill the void left by the withdrawal of competitor product, Axiron Eli Lilly has this month written to doctors to advise that it no longer holds the rights to distribute Axiron  (2% w/v transdermal testosterone solution). These now revert to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Forum: More than one pharmacist
Next "Safe pharmacy practice does not require a registered pharmacist to own a pharmacy"